Arbutus Biopharma Corp
ContraVir Stock Rose on Clinical Trial Progress Report
ContraVir Pharmaceuticals is focused on the development of antiviral therapies with a special focus on the development of anti-HBV therapies.
Why Arbutus Biopharma Stock Plunged 24.4% Today
Today, Arbutus Biopharma (ABUS) stock is trading at $6.87, which is a 24.42% decline from its October 8 closing price of $9.09.
Why Dicerna Pharmaceuticals Stock Rose 7.7% Yesterday
On September 13, Dicerna Pharmaceuticals (DRNA) stock rose 7.71% to $16.62 from its previous day’s close of $15.43.
Why Arrowhead Pharmaceuticals Stock Is Skyrocketing Today
Today, Arrowhead Pharmaceuticals (ARWR) stock is trading at $20.12, which represents ~42.7% growth from yesterday’s close of $14.10.